Home > News > Targeting Nanoparticles to Leukemia Cells and T-Lymphocytes
June 1st, 2005
Targeting Nanoparticles to Leukemia Cells and T-Lymphocytes
Abstract:
Investigators in Germany have developed a method for creating antibody-labeled gelatin nanoparticles that can target specific cells and then dissolve upon uptake by those cells, raising the possibility that gelatin nanoparticles could serve as biodegradable drug delivery vehicles. Reporting its work in the journal Biomaterials, a research team led by Hagen von Briesen, Ph.D., of the Fraunhofer Institute for Biomedical Engineering in St. Ingbert, Germany, showed that crosslinked gelatin nanoparticles could be readily labeled with an antibody that binds to the cell-surface protein CD3. This protein is found on the surface of certain types of leukemic T-lymphocytes.
Source:
NCI
Related Links |
Fraunhofer Institute for Biomedical Engineering
Related News Press |
Possible Futures
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
With VECSELs towards the quantum internet Fraunhofer: IAF achieves record output power with VECSEL for quantum frequency converters April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||